A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma - Brandes, Alba; Capper, David; Wick, Wolfgang (Neuro-Oncology, 2016)
Gesehen am 16.10.2018